Molecular Evidence of Drug Resistance in Asymptomatic Malaria Infections, Myanmar, 2015
Myat Htut Nyunt, Thinzar Shein, Ni Ni Zaw, Soe Soe Han, Fauzi Muh, Seong-Kyun Lee, Jin-Hee Han, Kyaw Zin Thant, Eun-Taek Han1 , and Myat Phone Kyaw1
Author affiliations: Department of Medical Research, Yangon, Myanmar (M.H. Nyunt, T. Shein, N.N. Zaw, S.S. Han, K.Z. Thant, M.P. Kyaw); Kangwon National University, Chuncheon, South Korea (M.H. Nyunt, S.-K. Lee, J.-H. Han, F. Muh, E.-T. Han)
Figure. The study site, Shwegyin Township, Myanmar, where molecular evidence of drug resistance in asymptomatic malaria infections was obtained. As of 2014, Myanmar artemisinin resistance containment areas were divided into Tier I (52 townships) and Tier II (all remaining townships).
1These authors contributed equally to this article.
Page created: February 17, 2017
Page updated: February 17, 2017
Page reviewed: February 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
Exit Notification / Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.